Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 2/2020

07.12.2019 | Original Article – Clinical Oncology

Insufficient examined lymph node count underestimates staging in pN3a patients after curative gastrectomy: a multicenter study with external validation

verfasst von: Yinping Dong, Yiran Qiu, Jingyu Deng, Wei Wang, Zhe Sun, Zhenning Wang, Zhiwei Zhou, Huimian Xu, Han Liang

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The present study aims to validate possible stage migration of lymph node metastasis related to the insufficient examined lymph node (ELN) count in pN3a gastric cancer (GC) patients.

Methods

1976 pN3 patients who underwent the R0 surgery in three high-capacity institutions in China were enrolled to explore the stage migration of nodal involvement, and 3146 pN3 cases from the Surveillance, Epidemiology, and End Results (SEER) Program Registry were used as an external validation cohort.

Results

After the propensity score matching of the Chinese cohort, the ELN count, as an independent predictor for GC outcome, was confirmed to be associated with the stage migration of lymph node metastasis in pN3a patients based on the univariate and multivariate survival analyses. Logistic regress was adopted to elucidate that the ELN count was an independent factor related to the long-term survival status of GC patients after curative surgery. Likelihood ratio test showed that the ELN count had the smallest Bayesian information criterion value among the clinicopathologic variables, corresponding to an efficient model to predict outcomes. Subsequently, stage migration of lymph node metastasis was predominantly detected in pN3a patient sub-group with insufficient (less than 16) ELN count, who presented with similar prognosis as the pN3b patients (P = 0.463) as per the stratum analysis with Kaplan–Meier. These methods were further validated using data from the SEER cohort, and the similar promising results were obtained.

Conclusion

pN3a patients with insufficient ELN count should be considered as pN3b cases to achieve accurate prognostic evaluation after curative gastrectomy.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Brierley J, Gospodarowicz MK, Wittekind C (2017) TNM classification of malignant tumours. Wiley, New York Brierley J, Gospodarowicz MK, Wittekind C (2017) TNM classification of malignant tumours. Wiley, New York
Zurück zum Zitat Coburn NG, Swallow CJ, Kiss A et al (2006) Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer 107:2143–2151CrossRef Coburn NG, Swallow CJ, Kiss A et al (2006) Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer 107:2143–2151CrossRef
Zurück zum Zitat Deng J, Liang H, Sun D et al (2008) Prognosis of gastric cancer patients with negative node metastasis following curative resection. Outcomes of the survival and recurrence. Can J Gastroenterol 22:835–839CrossRef Deng J, Liang H, Sun D et al (2008) Prognosis of gastric cancer patients with negative node metastasis following curative resection. Outcomes of the survival and recurrence. Can J Gastroenterol 22:835–839CrossRef
Zurück zum Zitat Deng JY, Liang H, Sun D et al (2009) Outcome in relation to numbers of nodes harvested in lymph node positive gastric cancer. Eur J Surg Oncol 35:814–819CrossRef Deng JY, Liang H, Sun D et al (2009) Outcome in relation to numbers of nodes harvested in lymph node positive gastric cancer. Eur J Surg Oncol 35:814–819CrossRef
Zurück zum Zitat Deng J, Zhang R, Pan Y et al (2014a) Comparison of the staging of regional lymph nodes using the sixth and seventh editions of the TNM classification system for the evaluation of overall survival in gastric cancer patients: findings of a case-control analysis involving a single institution in China. Surgery 156:64–74CrossRef Deng J, Zhang R, Pan Y et al (2014a) Comparison of the staging of regional lymph nodes using the sixth and seventh editions of the TNM classification system for the evaluation of overall survival in gastric cancer patients: findings of a case-control analysis involving a single institution in China. Surgery 156:64–74CrossRef
Zurück zum Zitat Deng J, Liang H, Ying G et al (2014b) Clinical significance of the methylated cytosine-phosphate-guanine sites of protocadherin-10 promoter for evaluating the prognosis of gastric cancer. J Am Coll Surg 219:904–913CrossRef Deng J, Liang H, Ying G et al (2014b) Clinical significance of the methylated cytosine-phosphate-guanine sites of protocadherin-10 promoter for evaluating the prognosis of gastric cancer. J Am Coll Surg 219:904–913CrossRef
Zurück zum Zitat Deng J, Yamashita H, Seto Y et al (2017) Increasing the number of examined lymph nodes is prerequisite for improvement accurate evaluation the overall survival of node-negative gastric cancer patients. Ann Surg Oncol 24:745–753CrossRef Deng J, Yamashita H, Seto Y et al (2017) Increasing the number of examined lymph nodes is prerequisite for improvement accurate evaluation the overall survival of node-negative gastric cancer patients. Ann Surg Oncol 24:745–753CrossRef
Zurück zum Zitat Deng J, Liu J, Wang W et al (2018) Validation of clinical significance of examined lymph node count for accurate prognostic evaluation of gastric cancer for the eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system. Chin J Cancer Res 30:477–491CrossRef Deng J, Liu J, Wang W et al (2018) Validation of clinical significance of examined lymph node count for accurate prognostic evaluation of gastric cancer for the eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system. Chin J Cancer Res 30:477–491CrossRef
Zurück zum Zitat Feinstein AR, Sosin DM, Wells CK (1985) The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312:1604–1608CrossRef Feinstein AR, Sosin DM, Wells CK (1985) The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312:1604–1608CrossRef
Zurück zum Zitat Hayashi S, Kanda M, Ito S et al (2019) Number of retrieved lymph nodes is an independent prognostic factor after total gastrectomy for patients with stage III gastric cancer: propensity score matching analysis of a multi-institution dataset. Gastric Cancer 22:853–863CrossRef Hayashi S, Kanda M, Ito S et al (2019) Number of retrieved lymph nodes is an independent prognostic factor after total gastrectomy for patients with stage III gastric cancer: propensity score matching analysis of a multi-institution dataset. Gastric Cancer 22:853–863CrossRef
Zurück zum Zitat In H, Solsky I, Palis B et al (2017) Validation of the 8th edition of the AJCC TNM staging system for gastric cancer using the national cancer database. Ann Surg Oncol 24:3683–3691CrossRef In H, Solsky I, Palis B et al (2017) Validation of the 8th edition of the AJCC TNM staging system for gastric cancer using the national cancer database. Ann Surg Oncol 24:3683–3691CrossRef
Zurück zum Zitat Jaehne J, Meyer HJ, Maschek H et al (1992) Lymphadenectomy in gastric adenocarcinoma: a prospective and prognostic study. Arch Surg 127:290–294CrossRef Jaehne J, Meyer HJ, Maschek H et al (1992) Lymphadenectomy in gastric adenocarcinoma: a prospective and prognostic study. Arch Surg 127:290–294CrossRef
Zurück zum Zitat Jiao XG, Deng JY, Zhang RP et al (2014) Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer. World J Gastroenterol 20:3640–3648CrossRef Jiao XG, Deng JY, Zhang RP et al (2014) Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer. World J Gastroenterol 20:3640–3648CrossRef
Zurück zum Zitat Liu YY, Fang WL, Wang F et al (2017) Does a higher cutoff value of lymph node retrieval substantially improve survival in patients with advanced gastric cancer?—Time to embrace a new digit. Oncologist 22:97–106CrossRef Liu YY, Fang WL, Wang F et al (2017) Does a higher cutoff value of lymph node retrieval substantially improve survival in patients with advanced gastric cancer?—Time to embrace a new digit. Oncologist 22:97–106CrossRef
Zurück zum Zitat Nakajima T (2002) Gastric cancer treatment guidelines in Japan. Gastric Cancer 5:1–5CrossRef Nakajima T (2002) Gastric cancer treatment guidelines in Japan. Gastric Cancer 5:1–5CrossRef
Zurück zum Zitat Sano T, Coit DG, Kim HH et al (2017) Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project. Gastric Cancer 20:217–225CrossRef Sano T, Coit DG, Kim HH et al (2017) Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project. Gastric Cancer 20:217–225CrossRef
Zurück zum Zitat Sobin L, Gospodarowicz M, Wittekind C (2009) TNM classification of malignant tumours, 7th edn. Wiley, New York Sobin L, Gospodarowicz M, Wittekind C (2009) TNM classification of malignant tumours, 7th edn. Wiley, New York
Metadaten
Titel
Insufficient examined lymph node count underestimates staging in pN3a patients after curative gastrectomy: a multicenter study with external validation
verfasst von
Yinping Dong
Yiran Qiu
Jingyu Deng
Wei Wang
Zhe Sun
Zhenning Wang
Zhiwei Zhou
Huimian Xu
Han Liang
Publikationsdatum
07.12.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 2/2020
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-019-03081-0

Weitere Artikel der Ausgabe 2/2020

Journal of Cancer Research and Clinical Oncology 2/2020 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.